NASDAQ: GLUE

Monte Rosa Therapeutics (GLUE) stock, explained like you're 5

Monte Rosa Therapeutics trades on the Nasdaq under the ticker GLUE. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 879 million dollars.

Ticker: GLUE
Exchange: Nasdaq
Sector: Healthcare
Industry: Biological Products (No Diagnostic Substances)
Size: Small cap, about 879 million dollars

Is Monte Rosa Therapeutics a small, medium or large cap company?

No. Monte Rosa Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 879 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Monte Rosa Therapeutics makes money

Selling medicines, medical devices or healthcare services.
Insurance premiums or hospital and clinic fees.
Research and licensing deals.

What moves GLUE stock

Results from clinical trials and approvals from regulators.
Drug prices, insurance rules and government policy.
Patents running out and new competing treatments.

In the news lately

BIOA, GLUE Stocks Clock Worst Day In Years What’s The NVO Connection? (Stocktwits)
(GLUE) Risk Channels and Responsive Allocation (Stock Traders Daily)
GLUE Oct 2026 22.500 call (GLUE261016C00022500) Stock Price, News, Quote & History (Yahoo! Finance Canada)
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stock Rated "Moderate Buy" by Sell Side Brokerages (MarketBeat)
Monte Rosa Therapeutics (Nasdaq:GLUE) Stock Analysis (Simply Wall Street)

Follow GLUE in your daily brief

Each trading day at 5 PM ET we post what happened to Monte Rosa Therapeutics and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow GLUE

Questions about Monte Rosa Therapeutics stock

What does Monte Rosa Therapeutics do?

What is the ticker symbol for Monte Rosa Therapeutics?

Monte Rosa Therapeutics trades under the ticker GLUE on the Nasdaq.

What is Monte Rosa Therapeutics's market cap?

Monte Rosa Therapeutics is a small cap stock with a market cap of about 879 million dollars.

How does Monte Rosa Therapeutics make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves GLUE stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow GLUE stock every day?

Add GLUE to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Similar stocks

Compare GLUE: GLUE vs ARGX, GLUE vs RVMD, GLUE vs BNTX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.